The Impact of Two Different Physical Therapy Programs in the Rehabilitation of Patients Undergoing Anterior Approach Hip Replacement Surgery

NCT ID: NCT04492462

Last Updated: 2021-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-22

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will look to determine two different types of physical therapy regimens in patients who undergo anterior total hip replacement. We will compare the results of two groups. The first group, the "Formal Physical Therapy" group, will undergo standard physical therapy following their surgery. They will see a physical therapist in a physical therapy office after their surgery. Here, the therapist will work with the patient to strengthen muscles and improve their walking. The second group, the "Self-directed Physical Therapy" group, will undergo physical therapy in the comfort of their own home using common household items (chairs, steps, etc). These patients will be given a list of exercises and stretches to perform on their own. It is our goal to prove that formal physical therapy is not needed after anterior hip replacements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Arthritis Total Hip Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Formal Physical Therapy

Group Type EXPERIMENTAL

Formal Physical Therapy

Intervention Type OTHER

Patients will undergo standard physical therapy following their surgery with a physical therapist in an office

Self-directed Physical Therapy

Group Type EXPERIMENTAL

Self-directed Physical Therapy

Intervention Type OTHER

Patients will undergo self-directed physical therapy in the comfort of their own home by completing a list of exercises and stretches without the direct supervision of a physical therapist in a physical therapist office

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Formal Physical Therapy

Patients will undergo standard physical therapy following their surgery with a physical therapist in an office

Intervention Type OTHER

Self-directed Physical Therapy

Patients will undergo self-directed physical therapy in the comfort of their own home by completing a list of exercises and stretches without the direct supervision of a physical therapist in a physical therapist office

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged between 18 and 80 years of age
* Patients undergoing primary anterior total hip arthroplasty for the diagnosis of osteoarthritis
* Patients with no previous invasive hip surgery (such as a previous hip replacement)

Exclusion Criteria

* Non-English speaking persons will be excluded in our study.
* Patients with a recent history (\<1 year) of heart attack, stroke, and lung clots.
* Previous invasive surgery on the hip undergoing replacement
* Patients with dementia, Parkinson's, or other neurological disorders
* Non-ambulatory patients
* Patients with impaired ability to consent, whether because of mental illness or otherwise
* Patients being discharged to a rehabilitation center
* Patients that experience intra-operative complications
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rutgers, The State University of New Jersey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephen Kayiaros MD

Principal Investigator, Clinical Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen T Kayiaros, MD

Role: PRINCIPAL_INVESTIGATOR

Rutgers University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Orthopaedic Associates

Somerset, New Jersey, United States

Site Status RECRUITING

Robert Wood Johnson Somerset Hospital

Somerville, New Jersey, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Daniel C Mascarenhas, MD

Role: CONTACT

732-235-7869

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stephen Kayiaros, MD

Role: primary

732-537-0909

Daniel C Mascarenhas, MD

Role: primary

732-235-7869

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro20140001090

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.